| Literature DB >> 31226358 |
Emilie Pollenus1, Bert Malengier-Devlies2, Leen Vandermosten1, Thao-Thy Pham1, Tania Mitera2, Hendrik Possemiers1, Louis Boon3, Ghislain Opdenakker2, Patrick Matthys4, Philippe E Van den Steen5.
Abstract
Neutrophil-depleting antibodies, such as anti-GR1 (RB6-8C5) and anti-Ly6G (1A8), are commonly used to study the in vivo function of neutrophils in murine disease models. Anti-Ly6G antibodies became the standard, because in contrast to anti-GR1, these do not bind Ly6C. The efficiency of the depletion needs to be carefully analysed as flow cytometry plots may be misinterpreted. For example, the staining intensity of GR1 on neutrophils (CD11b+ GR1hi) drops upon anti-Ly6G administration. We show that this drop is due to competition between anti-GR1 and anti-Ly6G antibodies. Neutrophil depletion with anti-Ly6G in naive mice was organ- and strain-specific. Furthermore, an incomplete anti-Ly6G-dependent neutrophil depletion was obtained in two immune-mediated mouse models, i.e. in malaria-infected C57BL/6 mice and in complete Freund's adjuvant (CFA)-challenged BALB/c mice. BrdU-incorporation studies show a slight increase in proliferating bone marrow neutrophils upon depletion in naive mice. Strikingly, depletion with anti-Ly6G in CFA-challenged BALB/c mice resulted in a significant increase in proliferating splenic neutrophils, causing a fast rebound of new immature neutrophils. In conclusion, our results emphasize the importance of careful panel design, gating strategies and duration of neutrophil depletion and highlight the context-dependent Ly6G depletion efficiency. It furthermore underlines the need for new tools to understand the in vivo role of neutrophils in immunological models.Entities:
Keywords: Anti-Ly6G antibodies; In vivo depletion; Murine immunological models; Neutrophil
Mesh:
Substances:
Year: 2019 PMID: 31226358 DOI: 10.1016/j.imlet.2019.06.006
Source DB: PubMed Journal: Immunol Lett ISSN: 0165-2478 Impact factor: 3.685